Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American (NY:SBS)

24.97 +0.49 (+2.00%)
Streaming Delayed Price Updated: 10:24 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American

< Previous 1 2 Next >
News headline image
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) Excels with Strong CAN SLIM Investment Profile ↗
SABESP (SBS) stock aligns with the CAN SLIM method, showing strong earnings growth, high profitability, and excellent technical momentum for potential gains. 
Via Chartmill
News headline image
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) Combines Strong Growth Momentum with Bullish Technical Setup ↗
Discover SBS: A top momentum stock with explosive 174% EPS growth and a perfect technical rating, poised for a breakout above $25. 
Via Chartmill
News headline image
SABESP (NYSE: SBS) Shows Strong Technical and Fundamental Growth Momentum ↗
SABESP stock shows strong technical momentum and explosive earnings growth, making it a top pick for systematic growth investors. 
Via Chartmill
News headline image
SABESP (NYSE:SBS) Stands Out as a Strong CAN SLIM Investment Candidate ↗
SABESP exemplifies the CAN SLIM method with strong earnings acceleration, high profitability, and technical momentum, making it a standout growth stock. 
Via Chartmill
News headline image
SABESP (NYSE:SBS) Emerges as a Strong CAN SLIM Investment Candidate ↗
SABESP (SBS) is a top CAN SLIM stock with strong earnings growth, high ROE, and market-leading momentum, making it a compelling growth candidate. 
Via Chartmill
News headline image
Earnings Scheduled For May 12, 2025 ↗
 
Via Benzinga
News headline image
Earnings Preview: Companhia De Saneamento ↗
 
Via Benzinga
News headline image
Is NYSE:SBS suited for CANSLIM investing? ↗
A fundamental analysis of (NYSE:SBS): High growth, ROE and relative strength for CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS), growth investors may appreciate this. 
Via Chartmill
News headline image
25 Stocks That Could Jump 100x According To This 40-Year Study ↗
 
Via Benzinga
News headline image
SABESP (NYSE:SBS) Emerges as a Top CANSLIM Growth Stock Pick ↗
Discover SABESP (SBS), a high-growth CANSLIM stock with strong earnings, solid momentum, and a leading role in Brazil's essential water utility sector. 
Via Chartmill
News headline image
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) Fits CAN SLIM Criteria with Strong Earnings Growth and Market Leadership ↗
SABESP (SBS) aligns with CAN SLIM strategy, showing strong earnings growth, market leadership, and technical strength, making it a potential high-momentum stock. 
Via Chartmill
News headline image
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) – A Strong Contender for CANSLIM Investors ↗
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) meets key CANSLIM criteria with strong earnings growth, high relative strength, and solid financials, making it a candidate for growth investors. 
Via Chartmill
News headline image
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) – A High Growth Momentum Stock with Strong Technical Setup ↗
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) combines strong earnings momentum with a high technical rating, making it a candidate for growth investors. The stock shows solid revenue and profit growth... 
Via Chartmill
News headline image
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) – A Strong Contender for CANSLIM Investors ↗
CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) meets key CANSLIM criteria with strong earnings growth, high relative strength, and solid fundamentals, making it a stock worth watching for growth investors. 
Via Chartmill
News headline image
A Look Into Companhia De Saneamento Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Cia Saneamento Basico (NYSE:SBS) – A Strong Growth Candidate Meeting Minervini’s Trend Template ↗
Cia Saneamento Basico (NYSE:SBS) meets Minervini’s Trend Template with strong technicals and high growth momentum, supported by surging earnings and revenue. A breakout above $21.06 could signal... 
Via Chartmill
News headline image
Companhia de Saneamento Basico (NYSE:SBS) - A High Growth Momentum Stock with Strong Technical Setup ↗
Companhia de Saneamento Basico (NYSE:SBS) shows strong earnings momentum and a bullish technical setup, making it a candidate for growth and breakout investors. 
Via Chartmill
News headline image
Why Cia Saneamento Basico de-ADR (NYSE:SBS) Stands Out for CANSLIM Investors ↗
Cia Saneamento Basico (NYSE:SBS) meets CANSLIM criteria with strong earnings growth, high relative strength, and solid fundamentals, making it a candidate for growth investors. 
Via Chartmill
News headline image
Why CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) qualifies as a high growth stock. ↗
Based on fundamental analysis, it turns out that CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) may be suited for growth investing, we'll explore why in this article. 
Via Chartmill
News headline image
The market is filled with gapping stocks in Thursday's session. ↗
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Why Mark Minervini may look into CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) ↗
A fundamental and technical analysis of (NYSE:SBS): Is CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) suited for high growth investing? 
Via Chartmill
News headline image
Earnings Scheduled For March 24, 2025 ↗
 
Via Benzinga
News headline image
Evaluating CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) for Growth Investment Opportunities. ↗
Is CIA SANEAMENTO BASICO DE-ADR (NYSE:SBS) suited for growth investing? We will dive into the fundamentals to answer this question in this article. 
Via Chartmill
News headline image
Reddit, Grab And Autodesk Are Among Top 11 Large-Cap Losers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio? ↗
11 worst performers last week: SYM (-25.83%), GRAB (-11.82%), RDDT (-10.97%), BBD (-10.88%), HTHT (-10.44%), VRT (-9.82%), ITUB (-8.53%), SBS (-8.40%), DELL (-8.16%), NTNX (-7.98%), ADSK (-7.98%) 
Via Benzinga
News headline image
SBS Stock Earnings: Companhia De Saneamento Beats EPS, Beats Revenue for Q2 2024 ↗
SBS stock results show that Companhia De Saneamento beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
SBS Stock Earnings: Companhia De Saneamento Meets EPS, Beats Revenue for Q1 2024 ↗
SBS stock results show that Companhia De Saneamento met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Nasdaq Down 100 Points; Crude Oil Drops Over 1% ↗
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Friday. The Dow traded down 0.43% to 33,164.71 while the NASDAQ fell 0.82% to 12,227.60. The... 
Via Benzinga
News headline image
Earnings Scheduled For November 10, 2022 ↗
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter. 
Via Benzinga
News headline image
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday ↗
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per... 
Via Benzinga
News headline image
Brazil Election Sends EWZ, SBS, VALE, PBR Stocks Soaring Today ↗
Today, a wide range of Brazilian stocks, including PBR stock, are seeing significant gains following a closer-than-expected election. 
Via InvestorPlace
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.